Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Aug 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

19 Aug 2015 Wright Reports 55 $75.00

MOSL: Aurobindo Pharma (Buy) - Strong quarter, US business to drive overall growth

AUROBINDO PHARMA 1QFY16: Strong quarter, US business to drive overall growth (ARBP IN, Mkt Cap USD7.2b, CMP INR761, TP INR88...

17 Aug 2015 Motilal Oswal Securities Ltd. 12 $115.00

Spark Capital: 1QFY16 outlook review of Aurobindo Pharma (Rating: Buy, TP: Rs. 869)

1QFY16 outlook review of Aurobindo Pharma (Rating: Buy, TP: Rs. 869) How does our one year outlook change? Aurobindo Pharm...

17 Aug 2015 Spark Capital Advisors(India) Private Limited 6 $46.00

Aurobindo Pharmaceuticals (ARBP) - Qtr. Update - August 14, 2015

Aurobindo Pharma (Bloomberg: ARBP IN, BUY, TP: Rs 880; 15% upside from CMP of Rs 766) Aurobindo’s (ARBP) Q1 EBITDA margin ...

17 Aug 2015 Axis Capital Limited 9 $92.00

Aurobindo Pharma Ltd. | Q1FY16 Result/Concall Update | Work-in-progress for building levers for high growth going forward; we raise our price target to Rs871 (from Rs800 earlier) and maintain BUY

Aurobindo Pharma Ltd. | Q1FY16 Result/Concall Update Work-in-progress for building levers for high growth going forward; we...

16 Aug 2015 IndiaNivesh Securities Pvt Ltd 5 $46.00

Aurobindo Pharma Ltd. | Q1FY16 First Cut Analysis | In-line performance for the quarter; robust ANDA pipeline keeps outlook intact

Aurobindo Pharma Ltd. | Q1FY16 First Cut Analysis In-line performance for the quarter; robust ANDA pipeline keeps outlook i...

13 Aug 2015 IndiaNivesh Securities Pvt Ltd 4 $35.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a phar...

11 Aug 2015 GlobalData 37 $125.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a phar...

16 Jun 2015 GlobalData 34 $125.00